About C&EN and ACS Publications

The largest print circulation among chemistry, pharmaceutical, and life sciences publications in the US and one of the largest in the world.

When you partner with our suite of publications, you create bonds with influential professionals at the world’s top pharmaceutical and biotechnology companies. Your message appears side-by-side with editorial content they trust most, as they stay current with the research and technology breakthroughs critical to their business.

Why C&EN? Products.

Our readers are actively shopping for your industry’s products:

67

Chemicals,Raw Materials & Specialties

62

Glassware/Consumables

37

Gases and Gas Equipment

32

Fine Chemicals/Specialty Chemicals

25

Tech/Computers/Software

8

Incubators/Refrigerator

Why ACS Publications?

With more than 50 journals to segment and target specific markets, you can reach millions of readers in your market segment anywhere in the world, including Europe and Asia. You’ll also have access to corporate subscribers from industry leaders like Pfizer, Merck, Bristol-Myers Squibb, GSK, Genentech and Amgen. Click here to learn more about ACS Journals, or browse the list of journals below related to the life sciences.

Speak to readers in drug discovery and manufacturing, across industry and academia. Place your one page ad alongside insights into the industry’s biggest and most promising drug prospects, or book an editorially-led webinar around this popular topic. 46% of our readers work in pharma and the life sciences industries specifically, and 97% of our audience are buyers, according to our 2017 survey.

Advertise in our Native Advertising Section:
Advances in Drug DevelopmentWhat are the current challenges and opportunities facing the pharmaceutical industry around the world? Another popular discussion for C&EN readers will be featured in this 2018 advertorial from C&EN.

More about Our Coverage

C&EN’s Pharmaceuticals track features a unique combination of stories on both the pharmaceutical industry and the fine chemical companies that serve it. Articles in the Drug Discovery, Development & Design sub-track are scientifically astute explorations of drug industry trends written by C&EN’s experienced pharma reporters. The annual New Drug Approvals story has become a must-read review of the FDA’s approval decisions. Here you’ll find a few of our upcoming issues that focus specifically on the pharmaceutical and life sciences markets.

Start generating more leads today with C&EN Advertising

Contact us now to find out how to build an integrated advertising campaign.